Suche
Kategorie
1091 Treffer
×
Forschungsprojekte
×
aktiv
×
Johannes Gutenberg-Universität Mainz
×
Hochschule Mainz
×
Theologische Fakultät Trier
×
Hochschule Koblenz
- Neo-Milk
- Eva, Mildenberger; Schmitz, Katharina; (2020 - 2024)
- PANIC - Elterliche Lebensqualität nach neonatologischer Intensivbehandlung
- Schönfeld, Mascha; Kidszun, André; Mildenberger, Eva; (2020 - 2024)
- Akustik
- Hergert, Frank; (ab 2020)
- FASCINATION (#1180)
- Radsak, Markus; (2020 - 2040)
- Charly - Haplo-Tx bei NHL (#1206)
- Wagner-Drouet, Maria; (2020 - 2040)
- SFB-TR-128 Project B05: Topological patterns of damage and compensation in chronic neuroinflammation
- Groppa, Sergiu; Muthuraman, Muthuraman; (2020 - 2024)
- TRADE-hypo (#1177)
- Alt, Jürgen; (2020 - 2040)
- deutsch-polnische bauhaus werkstatt – Future Text Research Group
- Stöffler, Anja; (ab 2019)
- Digitale Edition der Keilschrifttexte aus Haft Tappeh
- Homburg, Timo; Bruhn, Kai-Christian; Prechel, Doris; (2019 - 2025)
- Creative Entrepreneurship Rheinland-Pfalz
- Konrad, Elmar D.; (ab 2019)
- Die Quecksilbergrube "Treue Zuversicht".
- Haupt, Peter; (ab 2019)
- M4 – MUSEUM MODERNE MEDIEN MAINZ
- Stöffler, Anja; (ab 2019)
- Prospektionen auf dem Hérapel (Frankreich, Dép. Moselle)
- Haupt, Peter; (ab 2019)
- V114 in recipients of allogeneic hematopoietic stem cell transplant (#796)
- Teschner, Daniel; (2019 - 2040)
- A Phase I/II clinical trial for TCR modified T cells MDG1011in HR myeloid and lymphatic neoplasms (#799)
- Wagner-Drouet, Maria; (2019 - 2040)
- GMMG HD7 Trial (#789)
- Munder, Markus; Goldschmidt, Hartmut; (2019 - 2040)
- ARROW 2 Trial (#1116)
- Munder, Markus; Weisel, Katja; (2019 - 2040)
- Tumorantigene bei AML/MDS/MM (#1168)
- Wagner-Drouet, Maria; (2019 - 2040)
- DLBCL CD20+ ImbruVeRCHOP-Trial (#757)
- Heß, Georg; (2019 - 2040)
- INCB 01158-206 (#1151)
- Munder, Markus; (2019 - 2040)
- IMI.Gel001 (#1264)
- Radsak, Markus; (2019 - 2040)
- MPNSG (BiO)-Project in BCR-ABL1-negative Myeloid Neoplasms (#1141)
- Radsak, Markus; (2019 - 2040)
- Vision (#731)
- Alt, Jürgen; (2019 - 2040)
- ADVANCE II (#512)
- Wagner-Drouet, Maria; (2019 - 2040)
- BMS CA17-078: A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle Invasive Bladder Cancer
- Tsaur, Igor; Höfner, Thomas; Jäger, Wolfgang; (2019 - 2025)
- rrMCL PI3K Inhibitor_ CITADEL-205 / INCB 50465-205 (#767)
- Heß, Georg; (2019 - 2040)
- TOP-ART, NCT-PMO-1603 (#774)
- Kindler, Thomas; (2019 - 2040)
- GS-US-352-4365 (#788)
- Kindler, Thomas; (2019 - 2040)
- BMBF (FKZ: 13GW0403B): New Generation of an Artificial Skin Kit: Actively Induced Tissue Reconstruction (SKIN-ENERGY)
- Wang, Xiaohong; Müller, E.G.; (2019 - 2024)
- GO29781 (#795)
- Heß, Georg; (2019 - 2040)
- OLYMP-1 (#770)
- Heß, Georg; (2019 - 2040)
- DUO-O
- Hasenburg, Annette; Almstedt, Katrin; (2019 - 2027)
- Künstliche Intelligenz in Mediatheken und Marketing
- Pagel, Sven; Rothlauf, Franz; (ab 2019)
- The Nepal Heritage Documentation Project (NHDP)
- Boochs, Frank; (2018 - 2026)
- Business Model Innovation in the German Wine Industry
- Rosinus, Anna; (ab 2018)
- IT-Sicherheit und Datenschutz in der Cloud
- Pagel, Sven; (ab 2018)
- Molecular and clinical analysis of papillary thyroid carcinoma
- Musholt, J.; Staubitz, Julia; (2018 - 2025)
- Entwicklung von Controlling-Standards für die Sozialwirtschaft
- Moos, Gabriele; (ab 2018)
- Stellar Teens - CNTO1275PSO4056 - NIS
- Staubach-Renz, Petra; (2018 - 2024)
- GMMG-CONCEPT (#693)
- Munder, Markus; (2018 - 2025)
- PRAN-16-52 (#650)
- Kindler, Thomas; (2018 - 2040)
- Römisch-Mittelalterliche Wurzeln von Stadecken
- Haupt, Peter; (ab 2018)
- Allo-MM-PostCy-Study (#763)
- Wagner-Drouet, Maria; (2018 - 2040)
- FLT3 Maintenance (#702)
- Wagner-Drouet, Maria; (2018 - 2040)
- SAKK 36/13 (#730)
- Heß, Georg; (2018 - 2040)
- 1336.11 (#662)
- Alt, Jürgen; (2018 - 2040)
- ACE-LY-308 (#679)
- Heß, Georg; (2018 - 2040)
- LB-Y5-025 (#751)
- Teschner, Daniel; (2018 - 2040)
- Impassion 030 Alexandra
- Schmidt, Marcus; Almstedt, Katrin; (2018 - 2026)
- AGO Ovar 22: A Phase III, multicenter, randomized, study of Atezolizumab versus placebo administered in combination with Paclitaxel, Carboplatin and Bevacizumab to patients with newly diagnosed Stage III or Stage IV ovarian, Fallopian Tube or primary Peritoneal Cancer
- Hasenburg, Annette; Battista, Marco; (2018 - 2025)
- Humanist Computer Interaction auf dem Prüfstand
- Pagel, Sven; (ab 2017)
- Römisch-frühmittelalterliche Besiedlung im Umfeld der Kaiserpfalz Ingelheim
- Haupt, Peter; (ab 2017)
- Timeline
- Eisele, Petra; (2017 - 2099)
- Epigenetische Kontrolle leukämogener Genexpression durch Menin und MLL1-Komplexpartner-Proteine
- Kühn, Michael; (2017 - 2024)
- Frühe Eisengewinnung im Ingelheimer Wald
- Haupt, Peter; (ab 2017)
- MaiCo-MR
- Emrich, Tilman; (2017 - 2025)
- Ruxo-BEAT trial (#593)
- Kindler, Thomas; (2017 - 2040)
- Untersuchung zum HLA-DP-Mismatch bei allogener Stammzelltransplantation (#725)
- Wagner-Drouet, Maria; (2017 - 2040)
- JETS-Studie (#681)
- Wagner-Drouet, Maria; (2017 - 2040)
- AML_MDM2 antagonist, WO29519 Cytarabine (#643)
- Kindler, Thomas; (2017 - 2040)
- DETECT V /Chevendo
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- COMPASS
- Battista, Marco; Hasenburg, Annette; (2017 - 2025)
- Merit
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- ImPassion131
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- Fandango
- Battista, Marco; (2017 - 2025)
- Ruxo-allo-Studie (#631)
- Wagner-Drouet, Maria; (2017 - 2040)
- Precycle
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- SHAPE
- Hasenburg, Annette; Roxanna, Schwab; Seeger, Alexander; (2017 - 2025)
- REGSA
- Battista, Marco; Hasenburg, Annette; (2017 - 2025)
- Olympia
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- BrainMet
- Schmidt, Marcus; (2017 - 2025)
- Pallas
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- CRISP (#670)
- Alt, Jürgen; (2017 - 2040)
- Lyrikabend: Anthropozän. Schnittstelle zwischen Literatur und medialer Inszenierung
- Stöffler, Anja; (ab 2016)
- Das Zweite Vatikanum – Erbe und Auftrag
- Vellguth, Klaus; (2016 - 2025)
- Wissensmanagement und Digitalisierung
- Schreuder, Siegfried; (2016 - 2025)
- »Moholy-Nagy und die Neue Typografie«
- Eisele, Petra; Naegele, Isabel; (ab 2016)
- A randomized, 2x2 biomarker prevention trial of low-dose aspirin and metformin in colon cancer patients
- Roth, Wilfried; (2016 - 2024)
- CIK-Cell Study 01 (#583)
- Wagner, Maria; (2016 - 2040)
- HD 21 (#613)
- Beck, Joachim; (2016 - 2040)
- GMALL 08/2013 (#459)
- Beck, Joachim; (2016 - 2040)
- Apollo Trial (#630)
- Radsak, Markus; (2016 - 2040)
- Prostate Cancer Outcome (PCO) Studie
- Haferkamp, Axel; Tafel-Stein, Elke; (2016 - 2025)
- ATIR 101 (#596)
- Wagner-Drouet, Maria; (2016 - 2026)
- EMCL Register (#600)
- Heß, Georg; (2016 - 2040)
- TRIANGLE (#573)
- Heß, Georg; (2016 - 2040)
- ETAL3 ASAP (#592)
- Wagner, Maria; (2016 - 2040)
- AMLSG 21-13 (#539)
- Radsak, Markus; (2016 - 2040)
- HIFU Register:
- Höfner, Thomas; Böhm, Katharina; (2016 - 2030)
- HOS-Hunter Outcome Survey
- Hennermann, B; (2016 - 2025)
- FOS-Fabry Outcome Survey
- Hennermann, B; (2016 - 2025)